Mahamaya Lifesciences Limited is engaged in the manufacturing, registration, and export of crop protection products and bioproducts designed to enhance crop and soil health. The company supports the farming community by offering solutions that help improve agricultural productivity and protect crops from pests, diseases, and weeds.
The company primarily focuses on pesticide formulations and supplies bulk formulation products to leading Indian agrochemical companies as well as multinational corporations (MNCs). Mahamaya imports scientifically researched molecules, registers them with the Central Insecticides Board & Registration Committee (CIB&RC), and further develops them into technical-grade and value-added formulations for domestic and export markets.
The company has also created a strong presence in the international market through global product registrations, with active exports to Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, along with providing product data support required for registration and regulatory approvals in these regions.
Product Portfolio:
- Bulk Formulations: Acetamiprid SP, Buprofezin SC, Emamectin Benzoate SG, Imidacloprid SC, Paraquat Dichloride SC.
- Technical Grade: Acetamiprid Technical 99%, Atrazine Technical 95%, Imidacloprid Technical 95%, Emamectin Benzoate Technical 95%.
- Own Brands: MAYAMRIT GR, MAYAMRIT SL, MAYAGIBB, UCHIT EW 370.
- Export Products: Wiper (Sulphur 80% WDG), Lancha (Pendimethalin 50% EC), Tolfen (Tolfenpyrad 15% EC), Typic (Sulphur 80% WG).
Mahamaya Lifesciences IPO – Details
| IPO Opening Date | 11 November 2025 |
| IPO Closing Date | 13 November 2025 |
| Issue Type | Bookbuilding IPO |
| Issue Size | Total Issue: 61,78,800 Shares Worth ₹70.44 Crore Fresh Issue: 56,38,800 Shares Worth ₹64.28 Crore Offer For Sale: 5,40,000 Shares Worth ₹6.16 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹108 – ₹114 per share |
| Market Lot | 1200 Shares |
| Min Order | 1200 Shares [ 1 Lot ] |
| Listing At | NSE SME |
| Registrar | Kfin Technologies Ltd. |
| QIB Shares Offered | 50% |
| NII Shares Offered | 15% |
| Retail Shares Offered | 35% |
Mahamaya Lifesciences IPO – Date Schedule
| IPO Open Date | 11 November 2025 |
| IPO Close Date | 13 November 2025 |
| Basis of Allotment | 14 November 2025 |
| Initiation of Refund | 17 November 2025 |
| Credit of Shares to Demat | 17 November 2025 |
| IPO Listing Date | 18 November 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on November 13, 2025 |
Mahamaya Lifesciences IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | ₹2,73,600 |
| Retail (Max) | 2 | 2,400 | ₹2,73,600 |
| S-HNI (Min) | 3 | 3,600 | ₹4,10,400 |
| S-HNI (Max) | 7 | 8,400 | ₹9,57,600 |
| B-HNI (Min) | 8 | 9,600 | ₹10,94,400 |
Competitive Strength
- Experienced management team consisting of experts.
- Capability to introduce vital products for Indian Agriculture.
- Development of export opportunities of products.
- Ability to develop brands.
- Cordial relationships with suppliers of raw materials.
- Core values focused on achieving sustainability through innovative approaches.
Company Promoters
- Mr. Krishnamurthy Ganesan
- Mrs. Lalitha Krishnamurthy
- Mr. Prashant Krishnamurthy
Company Financials
| Period | Total Revenue | Total Expense | Profit After Tax | Total Borrowings |
|---|---|---|---|---|
| 31 March 2023 | ₹137.40 Cr | ₹132.30 Cr | ₹3.75 Cr | ₹24.37 Cr |
| 31 March 2024 | ₹162.83 Cr | ₹155.71 Cr | ₹5.22 Cr | ₹54.63 Cr |
| 31 March 2025 | ₹267.17 Cr | ₹249.81 Cr | ₹12.94 Cr | ₹58.11 Cr |
| 30 June 2025 | ₹84.04 Cr | ₹78.35 Cr | ₹4.10 Cr | ₹57.72 Cr |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 34.94% |
| ROCE | 23.15% |
| Debt/Equity | 1.08 |
| RoNW | 26.19% |
| PAT Margin | 4.84% |
| EBITDA Margin | 9.22% |
| Price to Book Value | 9.40 |
| Market Capitalization | 266.82 Cr |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 7.29 | 7.01 |
| P/E (x) | 15.65 | 16.25 |
Object Of The Issue
| Objects of the Issue | Expected Amount (in Crore) |
|---|---|
| Purchase of Equipment for existing Formulation plant. | ₹3.75 |
| Funding capital expenditure towards setting up a new technical manufacturing plant. | ₹29.42 |
| Construction of Warehouse Building and Purchase of Machinery. | ₹2.53 |
| Funding the working capital requirement of the Company. | ₹18.00 |
| General Corporate Purposes. | – |
✅Strengths
- Experienced and technically strong management team.
- Established relationships with domestic agrochemical companies and MNCs.
- Focus on bio-based and eco-friendly crop care products.
- Dealer network enabling branded product reach across states.
- Steady growth in revenue and profitability.
⚠️Risks
- Business depends on regulatory approvals for product registrations.
- Raw material prices and imports may impact margins.
- Competitive agrochemical industry with large established players.
- Working capital-intensive business model.
- Strict environmental and safety compliance requirements.
Mahamaya Lifesciences IPO Promoter Holding
| Pre Issue Share Holding | 77.27% |
| Post Issue Share Holding | 56.35% |
Mahamaya Lifesciences IPO Prospectus
Company Contact Information
| Mahamaya Lifesciences Ltd. Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, Block, Okhla, Phase – 1 Delhi, New Delhi, 110020 Phone: +91-1146561474 Email: cs@mahamayalifesciences.com Website: https://www.mahamayalifesciences.com/ |
Mahamaya Lifesciences IPO Registrar
| Kfin Technologies Ltd. Phone: 04067162222, 04079611000 Email: mahamaya.ipo@kfintech.com Website: https://ipostatus.kfintech.com/ |
Mahamaya Lifesciences IPO Lead Manager(s)
| . Oneview Corporate Advisors Pvt.Ltd |
Mahamaya Lifesciences IPO FAQ
| What is Mahamaya Lifesciences IPO? Mahamaya Lifesciences IPO is an SME IPO. The issue is priced at ₹108 – ₹114 per equity share. The IPO is to be listed on BSE SME. |
| When Mahamaya Lifesciences IPO will open? The IPO is to open on 11 November 2025 for QIB, NII, and Retail Investors. |
| What is Mahamaya Lifesciences IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| What is the Mahamaya Lifesciences IPO Size? Mahamaya Lifesciences IPO size is ₹70.44 Crore. |
| What is Mahamaya Lifesciences IPO Minimum and Maximum Lot Size for Retail? The minimum bid is 2,400 Shares with ₹2,73,600 amount, while the maximum bid is 2,400 Shares with ₹2,73,600. |
| What is the Mahamaya Lifesciences IPO Allotment Date? Mahamaya Lifesciences IPO allotment date is 14 November 2025. |
| What is the Mahamaya Lifesciences IPO Listing Date? Mahamaya Lifesciences IPO listing date is 18 November 2025. The IPO is to be listed on the NSE SME. |
